Financial Counselors Inc. lessened its position in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 1.0% during the 3rd quarter, Holdings Channel reports. The institutional investor owned 17,041 shares of the company’s stock after selling 170 shares during the period. Financial Counselors Inc.’s holdings in Colgate-Palmolive were worth $1,769,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Gordian Advisors LLC purchased a new position in shares of Colgate-Palmolive during the 3rd quarter valued at approximately $602,000. Carrera Capital Advisors lifted its holdings in Colgate-Palmolive by 23.1% during the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock valued at $4,066,000 after purchasing an additional 7,353 shares in the last quarter. Vontobel Holding Ltd. grew its position in shares of Colgate-Palmolive by 224.6% in the third quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company’s stock valued at $82,626,000 after purchasing an additional 550,750 shares during the period. PGGM Investments grew its position in shares of Colgate-Palmolive by 171.8% in the second quarter. PGGM Investments now owns 157,608 shares of the company’s stock valued at $15,294,000 after purchasing an additional 99,624 shares during the period. Finally, QRG Capital Management Inc. increased its stake in shares of Colgate-Palmolive by 11.2% during the second quarter. QRG Capital Management Inc. now owns 57,275 shares of the company’s stock worth $5,558,000 after purchasing an additional 5,751 shares in the last quarter. Hedge funds and other institutional investors own 80.41% of the company’s stock.
Analyst Ratings Changes
CL has been the topic of several research analyst reports. TD Cowen lowered their price objective on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a report on Monday, October 28th. JPMorgan Chase & Co. lifted their price target on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Wells Fargo & Company reduced their price objective on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a research note on Monday, October 28th. Piper Sandler began coverage on shares of Colgate-Palmolive in a research note on Tuesday, September 24th. They set an “overweight” rating and a $121.00 target price on the stock. Finally, StockNews.com raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research note on Monday, November 25th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus price target of $105.11.
Insider Transactions at Colgate-Palmolive
In other news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.34% of the company’s stock.
Colgate-Palmolive Price Performance
Shares of CL opened at $96.60 on Friday. The firm has a 50-day simple moving average of $97.38 and a two-hundred day simple moving average of $98.58. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68. Colgate-Palmolive has a 1-year low of $75.50 and a 1-year high of $109.30. The stock has a market cap of $78.92 billion, a PE ratio of 27.68, a P/E/G ratio of 3.45 and a beta of 0.42.
Colgate-Palmolive Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.07%. The ex-dividend date of this dividend was Friday, October 18th. Colgate-Palmolive’s dividend payout ratio (DPR) is 57.31%.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More
- Five stocks we like better than Colgate-Palmolive
- How to Invest in Biotech Stocks
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- How to invest in marijuana stocks in 7 stepsĀ
- 3 Penny Stocks Ready to Break Out in 2025
- Comparing and Trading High PE Ratio Stocks
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.